JAZZ
Jazz PublicANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
JAZZ vs peer average
74/100
JAZZ vs. peer average (A vs. B)
Grade spread
A 4 · C 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
BBIO is the first available peer comparator.
BridgeBio is another mid-cap biotech with high catalyst intensity, though its model is more development-binary and less cash-generative than Jazz's established commercial portfolio.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JAZZ
Jazz Public
BBIO
BridgeBio
Grade
A
C
Momentum
89
27
Value
63
41
Sentiment
49
79
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs BBIO
JAZZ / BBIO
Grade Position
Above peers
JAZZ vs. peer average (A vs. B)
74/100
Momentum
89
JAZZValue
63
JAZZSentiment
49
BBIORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JAZZ
BBIO is the first peer returned for this comparison set.